Danaher (NYSE:DHR) Updates FY19 Earnings Guidance

Danaher (NYSE:DHR) issued an update on its FY19 earnings guidance on Thursday morning. The company provided earnings per share guidance of $4.75-4.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.85. Danaher also updated its FY 2019 guidance to $4.75-4.80 EPS.

NYSE DHR traded down $1.39 during trading hours on Friday, hitting $141.61. 3,821,795 shares of the company’s stock traded hands, compared to its average volume of 2,343,584. Danaher has a 52-week low of $94.59 and a 52-week high of $145.50. The company has a market cap of $102.38 billion, a P/E ratio of 31.33, a PEG ratio of 2.58 and a beta of 0.96. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average is $140.27.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.04. Danaher had a net margin of 12.22% and a return on equity of 11.73%. The company had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same quarter in the prior year, the company earned $1.15 EPS. Danaher’s revenue was up 3.5% compared to the same quarter last year. On average, equities research analysts predict that Danaher will post 4.78 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, June 27th. This represents a $0.68 annualized dividend and a yield of 0.48%. Danaher’s dividend payout ratio is presently 15.04%.

Several analysts recently issued reports on DHR shares. Zacks Investment Research cut shares of GALP ENERGIA SG/ADR from a hold rating to a sell rating in a research note on Monday, May 6th. Wolfe Research started coverage on shares of Waters in a research note on Thursday, May 30th. They set an underperform rating for the company. Robert W. Baird upped their price objective on shares of Danaher from $131.00 to $148.00 and gave the company an outperform rating in a research note on Friday. Janney Montgomery Scott boosted their target price on shares of Danaher from $136.00 to $174.00 and gave the company a buy rating in a report on Wednesday, April 17th. Finally, Needham & Company LLC reiterated a buy rating and issued a $155.00 target price (up from $142.00) on shares of Danaher in a report on Friday. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Danaher has a consensus rating of Buy and an average price target of $139.08.

In other news, Director Donald J. Ehrlich sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $132.95, for a total value of $664,750.00. Following the transaction, the director now directly owns 100,603 shares in the company, valued at approximately $13,375,168.85. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $131.30, for a total transaction of $24,143,181.40. Following the completion of the transaction, the chief executive officer now owns 302,377 shares in the company, valued at $39,702,100.10. The disclosure for this sale can be found here. Insiders sold a total of 453,448 shares of company stock worth $59,724,640 over the last quarter. 11.40% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: How to find the components of the quick ratio

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.